In vivo evaluation of a new ligand with picomolar affinity for the serotonin tran

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$500,000.00
Award Year:
2008
Program:
SBIR
Phase:
Phase I
Contract:
1R43MH079568-01A1
Agency Tracking Number:
MH079568
Solicitation Year:
2008
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2007-2
Small Business Information
MOLECULAR NEUROIMAGING, LLC
MOLECULAR NEUROIMAGING, LLC, 60 TEMPLE STREET, SUITE 8A, NEW HAVEN, CT, 06510
Hubzone Owned:
Y
Socially and Economically Disadvantaged:
Y
Woman Owned:
Y
Duns:
020285081
Principal Investigator:
GILLES TAMAGNAN
(203) 401-4309
GTAMAGNAN@INDD.ORG
Business Contact:
(203) 401-4351
jmariotti@indd.org
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): The goal of this research project is to validate in humans a new ligand with picomolar affinity for the serotonin transporter. It will permit quantitative measurement of serotonin transporter (5- HTT) sites in living br ain by imaging with single photon emission tomography (SPECT). The serotonin transporter is known to play a critical role in several physiological and pathophysiological processes, including depression, anxiety, seasonal affective disorder, bulimia, and ps ychosis, as demonstrated by post-mortem data, clinical efficacy of therapies affecting this target site, and imaging studies. A radiotracer that binds specifically to 5-HTT is of great utility in diagnosis, monitoring treatment, and research of these disor ders. There is a need for better tracers that allow quantitation in areas of the brain with low 5-HTT densities such as the cortex.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government